- Home
- TWST vs GENI Comparison
TWST vs GENI Comparison
Compare TWST & GENI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWST
- GENI
- Stock Information
- Founded
- TWST 2013
- GENI 2016
- Country
- TWST United States
- GENI United Kingdom
- Employees
- TWST N/A
- GENI N/A
- Industry
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- GENI Services-Misc. Amusement & Recreation
- Sector
- TWST Health Care
- GENI Consumer Discretionary
- Exchange
- TWST Nasdaq
- GENI Nasdaq
- Market Cap
- TWST 2.6B
- GENI 2.1B
- IPO Year
- TWST 2018
- GENI N/A
- Fundamental
- Price
- TWST $38.21
- GENI $10.25
- Analyst Decision
- TWST Buy
- GENI Strong Buy
- Analyst Count
- TWST 10
- GENI 12
- Target Price
- TWST $52.50
- GENI $11.79
- AVG Volume (30 Days)
- TWST 1.0M
- GENI 4.2M
- Earning Date
- TWST 05-01-2025
- GENI 05-07-2025
- Dividend Yield
- TWST N/A
- GENI N/A
- EPS Growth
- TWST N/A
- GENI N/A
- EPS
- TWST N/A
- GENI N/A
- Revenue
- TWST $330,189,000.00
- GENI $510,894,000.00
- Revenue This Year
- TWST $22.62
- GENI $23.33
- Revenue Next Year
- TWST $17.76
- GENI $16.38
- P/E Ratio
- TWST N/A
- GENI N/A
- Revenue Growth
- TWST 25.85
- GENI 23.71
- 52 Week Low
- TWST $27.41
- GENI $4.91
- 52 Week High
- TWST $60.90
- GENI $11.16
- Technical
- Relative Strength Index (RSI)
- TWST 39.46
- GENI 55.50
- Support Level
- TWST $37.12
- GENI $9.53
- Resistance Level
- TWST $40.80
- GENI $11.16
- Average True Range (ATR)
- TWST 2.48
- GENI 0.53
- MACD
- TWST -0.12
- GENI -0.01
- Stochastic Oscillator
- TWST 13.41
- GENI 57.13
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.